AzTrials
AzTrials

Falls (Accidents) in Old AgeFT-CNCT03961386

FallsTalk Falls Prevention Program for Caregivers and Persons With Memory Loss or Dementia

A study testing FallsTalk-C and FallsTalk in people with Falls (Accidents) in Old Age, run by Brookside Research & Development Company at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This randomized-control trial involves dyads consisting of a family caregiver (CG) and a person with memory loss or dementia (PwD). The FallsTalk Caregiver Resource System (FT-C) intervention is administered by the CG, whose role is to modify their interactions with the PwD. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Falls (Accidents) in Old Age
What is being tested?
FallsTalk-C and FallsTalk
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
13 Mar 2019to May 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Caregiver (CG) Inclusion Criteria:

  • residence in western Washington state
  • minimum age= 18
  • family CG
  • primary CG
  • some daily personal contact with Person with Dementia (PwD) for 1 month
  • basic computer skills and telephone access
  • able to commit to 6 month study.

Persons with Dementia (PwD) Inclusion Criteria:

  • living at home with residence in western Washington state
  • minimum age= 55
  • at least one fall in last 6 months or regular loss of balance
  • can ambulate at least 6 feet
  • ability to communicate thoughts
  • willingness to participate.

CG Exclusion Criteria:

  • Professional CG (unless primary CG for family member)
  • distance CG unable to be physically present with PwD daily for 1 month
  • terminal illness with less than 6 months to live
  • CG has significant memory loss.

PwD Exclusion Criteria:

  • Residence outside of western Washington state
  • Living in Residential care setting
  • non-communicative
  • terminal illness with less than 6 months to live
  • wheel chair or bed bound.

Trial locations and contacts

1 site in 1 country.

Brookside R&D contact

206-317-3173

Info@FallScape.org

United States1 site, 1 recruiting
  • Brookside Research & Development

    Freeland, Washington, 98249

    Victoria Panzer, PhD, 206-317-3173, VPBrookside@fallscape.org

    Kristin Koontz, RN, 206-317-3173, Info@fallscape.org

    Recruiting

Other trials in United States

About this study

Official title: Development of a Prototype FallsTalk Caregiver Resource System

This randomized-control trial involves dyads consisting of a family caregiver (CG) and a person with memory loss or dementia (PwD). The FallsTalk Caregiver Resource System (FT-C) intervention is administered by the CG, whose role is to modify their interactions with the PwD. FT-C will create a 3-way partnership between an Interventionist and the dyad, capitalizing on CG-PwD interactions. The PwD will be observed by the CG and both will be evaluated by the study team. Brief daily FT-C intervention by the CG will stimulate the PwD's awareness and individualized weekly CG- check-ins with the Interventionist will increase the CG's skills. Our hypothesis is that FT-C will increase PwD's awareness of personal fall threats and encourage new falls prevention behaviors, resulting in reduced fall rates.

Read the detailed description

This is a single-site preliminary trial enrolling dyads in Western Washington state only.

Being tested
FallsTalk-C, FallsTalk
Keywords
prevention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FallsTalk-CBehavioural

    The FT-C experimental intervention involves two face-to-face visits including Initial and Follow-up Interviews, CG training, daily interaction with the PwD using a computer with FT-C software, weekly check-in calls, weekly postcard completion and monthly check-in calls for at least six months and up to one year.

  • FallsTalkBehavioural

    Also called Attentional control- the same number of steps and an equivalent amount of time is devoted to these participants.

    The FallsTalk intervention involves two face-to-face visits including Initial and Follow-up Interviews,CG training, daily interaction with the PwD, weekly check-in calls, weekly postcard completion and monthly check-in calls for at least six months and up to one year.

Study groups in NCT03961386
Study groupRoleWhat they receive
FallsTalk-CExperimentalFallsTalk CG intervention
Receives: Behavioral: FallsTalk-C; Behavioral: FallsTalk
FallsTalkActive comparatorFallsTalk intervention
Receives: Behavioral: FallsTalk
PostCardOnlyNo interventionPostcard only- Control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of falls

    number of falls per month

    Measured: weekly for up to one year

  2. Change of Residence

    Report of change of primary residence

    Measured: weekly for up to one year

Secondary outcomes (4)
  1. Fall Threat Awareness

    Ability to identify potential fall risks in 10 standardized novel multimedia clips administered in random order

    Measured: Pre-test- 5 clips at Initial interview; Post-test- 5 clips at Follow-up interview one month later

  2. Activity-Specific Balance Confidence scale

    The Activity-Specific Balance Confidence scale is a standardized 16 item scale that measures an individual's self-efficacy about preventing a fall or loss of balance. The maximum score is 1600. Each item is scored from 0-100 with 0 indicating no confidence and 100 meaning complete confidence.

    Measured: Pre-test at Initial interview; Post-test at Follow-up interview one month later

  3. Caregiver Falls Prevention Concerns

    Specific concerns identified by Caregiver with respect to preventing falls in the person they care for.

    Measured: Survey administered at study entry and Follow-up visit.

  4. Burden Scale for Family Caregivers

    The Burden Scale for Family Caregivers is a standardized 28 item scale that assesses subjective burden of the CG. The items are scored as strongly agree, agree, disagree or strongly disagree and the maximum score is 84. A score of 0 indicates no burden and a score of 84 indicates a very severe burden with a high risk of psychosomatic symptoms.

    Measured: BSFC is administered at Initial interview and Follow-up interview one month later.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2019
  2. Study start13 Mar 2019
  3. Primary completionDec 2019 (estimated)
  4. Study completionMay 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03961386
Sponsor's protocol ID
FT-Cv1.1
Other IDs
R43AG058399
Acronym
FT-C
Status last verified
Jun 2019
First submitted
22 May 2019
Last updated
6 Jun 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing FallsTalk-C and FallsTalk in people with Falls (Accidents) in Old Age, run by Brookside Research & Development Company at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Jun 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Brookside R&D (206-317-3173, Info@FallScape.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of falls (time frame: weekly for up to one year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in